NVV1.F • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold NVV1.F in your mock portfolio yet.
The low PE ratio of 4.43 and positive EPS of 1.68 indicate that Novavax is currently profitable and valued cheaply on an earnings basis. However, without visibility into the durability of these earnings and given the company’s historically volatile fundamentals, the valuation may reflect market skepticism about future profitability. Overall, the financial picture looks optically attractive but carries meaningful execution and sustainability risk.
The stock has gained 21.8% over the last month and is trading above its 200-day moving average, indicating a positive short- to medium-term momentum shift. However, an RSI of 68.02 places the shares near overbought territory, suggesting that the recent rally may be stretched and vulnerable to pullbacks. Technically, the setup is improving but not yet convincingly in a sustained uptrend.
Alternative data points show weak or declining engagement and hiring, which can signal softer underlying business momentum or a more defensive posture by management. Website traffic is modest, job openings have fallen sharply, and most social channels are seeing slight follower declines, with only LinkedIn showing marginal growth. Overall, these signals lean negative for near-term demand and growth sentiment.
Novavax’s current profitability and very low PE multiple, combined with recent positive price momentum above the 200-day moving average, create a potentially attractive value and technical setup. However, the near-overbought RSI, weak alternative data signals, and implied concerns about earnings durability temper the outlook. Overall, the balance of factors supports a neutral stance, with both upside optionality and meaningful downside risk.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: